Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
As the beginning of the COVID-19 pandemic, numerous attempts have been made to identify specific antiviral mouth rinses which may help reduce the salivary viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Although the results from in vivo well-controlled clinical studies are...
Main Authors: | Vishakha Grover, Varinder Kumar, Veena Puri, Ashish Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Indian Society of Periodontology |
Subjects: | |
Online Access: | http://www.jisponline.com/article.asp?issn=0972-124X;year=2022;volume=26;issue=5;spage=512;epage=514;aulast=Grover |
Similar Items
-
Chlorhexidine: An effective anticovid mouth rinse
by: Ashish Jain, et al.
Published: (2021-01-01) -
Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing
by: Abhishek Chaurasiya, et al.
Published: (2023-02-01) -
Designing Inhibitors for the SARS CoV Main Protease as Anti-SARS Drugs
by: Hamza Bari, et al.
Published: (2020-12-01) -
Molecular docking reveals fibrinogen binding sites on SARS-CoV-2 spike protein: A potential mechanism for COVID-19-related coagulation
by: Onur Ozturk, et al.
Published: (2024-04-01) -
Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
by: Dimpal Thakuria, et al.
Published: (2022-06-01)